Favezelimab in Combination with Pembrolizumab in Patients with Anti-PD-1-Naive Relapsed or Refractory Classical Hodgkin Lymphoma: Updated Analysis of an Open-Label Phase 1/2 StudyNathalie A. Johnson,David Lavie,Peter Borchmann, Gareth P. Gregory,Alex F. Herrera,Leonard Minuk,Vladan Vucinic,Philippe Armand,Abraham Avigdor,Robin Gasiorowski,Yair Herishanu,Colm Keane,John Kuruvilla,Rachel Marceau West,Pallavi Pillai,Patricia Marinello,John TimmermanBlood（2023）引用 0|浏览7暂无评分AI 理解论文溯源树样例生成溯源树，研究论文发展脉络Chat Paper正在生成论文摘要
